Casirivimab and Imdevimab for Early Asymptomatic SARS-CoV-2 Infection, Hypothermia vs Normothermia for Cardiogenic Shock and Extracorporeal Membrane Oxygenation, Familial Idiopathic Dilated Cardiomyopathy, and more
Editor’s Summary by Linda Brubaker, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 1, 2022, issue.
Source: JAMA: This Week's Audio Commentary - Category: General Medicine Authors: JAMA Network Source Type: podcasts
More News: American Medical Association (AMA) | Cardiogenic Shock | Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | General Medicine | Heart | Hypothermia | SARS